Table 1

Baseline and clinical characteristics of study population in the control and DCM diseased group
Control (n = 4) DCM (n = 4)
Age (years) 9.3 ± 2.1 7.9 ± 3.3
Body weight (kg) 39.3 ± 8.9 36.6 ± 4.5
Gender (male/female) 2/2 3/1
VPCs/24 hours 12.75 ± 15.39 2748 ± 4842*
LVEDV (ml/m2) 67.68 ± 11.60 120.30 ± 3.85*
LVESV (ml/m2) 33.63 ± 7.45 72.50 ± 2.85*
EF (%) 49.83 ± 6.37 39.67 ± 3.68*
Urea (mmol/l) 6.00 ± 0.68 4.80 ± 1.22
Creatinine (μmol/l) 62.25 ± 6.40 65.00 ± 6.58
cTnI (ng/ml) ≤ 0.20 0.36 ± 0.04*
total RNA (ng/μl) 3.63 ± 0.33 4.23 ± 1.23

Age, body weight, VPCs, LVEDV, LVESV, EF, urea, creatinine, cTnI and total RNA values in mean ± SD. cTnI ≤ 0.2 representing values under the detectable limit. DCM: Dilated cardiomyopathy; VPCs/24 hours: ventricular premature complexes in 24 hours; LVEDV: left ventricular end-diastolic volume; LVESV: left ventricular end-systolic volume; EF: left ventricular ejection fraction; cTnI: cardiac troponin I; RNA: Ribonucleic acid. * p < 0.05 vs control.

Steudemann et al.

Steudemann et al. BMC Veterinary Research 2013 9:12   doi:10.1186/1746-6148-9-12

Open Data